Literature DB >> 10935045

T-cell lymphoproliferative disorder in an aged rhesus macaque.

K V Gilardi1, A Spinner, D R Canfield, C R Valverde, S Hatcher, E Larkin, J Roberts, M McChesney.   

Abstract

A CD8+ T-cell leukemia was diagnosed in an aged female rhesus macaque. Although leukemia and lymphoma in nonhuman primates are commonly associated with simian T-lymphotropic virus, gibbon ape leukemia virus, oncogenic herpesviruses, and types C, D, and E retroviruses, this monkey was not infected with any of these viruses. However, the monkey did have antibodies against herpesvirus saimiri. This likely represents cross-reactivity of the herpesvirus saimiri assay with rhesus monkey rhadinovirus (RRV) antibodies; RRV was first described in rhesus macaques that were identified as having antibodies against herpesvirus saimiri. Rhesus rhadinovirus is a gamma herpesvirus, related antigenically to herpesvirus saimiri and Kaposi's sarcoma-associated herpesvirus (KSHV), which have been linked to lymphoproliferative disorders in primates and humans, respectively. Moreover, an oncogene has been recently identified in the RRV genome that is equivalent in position to the herpesvirus saimiri and KSHV oncogenes. Presently, the association of RRV infection with disease in nonhuman primates is unknown.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10935045     DOI: 10.2460/javma.2000.217.384

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  2 in total

1.  Nucleocytoplasmic shuttling of human cytomegalovirus UL84 is essential for virus growth.

Authors:  Yang Gao; Dominique Kagele; Kate Smallenberg; Gregory S Pari
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

2.  A conserved Eph family receptor-binding motif on the gH/gL complex of Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus.

Authors:  Anna K Großkopf; Armin Ensser; Frank Neipel; Doris Jungnickl; Sarah Schlagowski; Ronald C Desrosiers; Alexander S Hahn
Journal:  PLoS Pathog       Date:  2018-02-12       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.